Biotest AG/ DE0005227201 /
| 9/20/2023 9:21:12 AM | Chg. - | Volume | Bid- | Ask5:29:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 40.30EUR | - | 5,943 Turnover: 239,819.60 |
-Bid Size: - | -Ask Size: - | 2.41 bill.EUR | - | 12.69 |
Assets
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
2024 - EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 522.2000 | 524.7000 | 520.3000 | 522.4000 | - | ||||||
| Intangible Assets | 14 | 11.3000 | 9.2000 | 9 | - | ||||||
| Long-Term Investments | .2000 | 5.6000 | 5.1000 | 11.3000 | - | ||||||
| Fixed Assets | 575 | 582 | 583.6000 | 654.4000 | - | ||||||
| Inventories | 290.1000 | 244.6000 | 293.8000 | 419.1000 | - | ||||||
| Accounts Receivable | 115.8000 | 107.3000 | 124.5000 | 145.2000 | - | ||||||
| Cash and Cash Equivalents | 71.3000 | 104.4000 | 116.6000 | 108.1000 | - | ||||||
| Current Assets | 556.3000 | 522.2000 | 619.4000 | 756.5000 | - | ||||||
| Total Assets | 1,131.3000 | 1,104.2000 | 1,203 | 1,410.9000 | - | ||||||
Liabilities
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
2024 - EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 42 | 38.8000 | 51.1000 | 78.1000 | - | ||||||
| Long-term debt | 462.5000 | 496.4000 | 612.8000 | 429.7000 | - | ||||||
| Liabilities to Banks | 470.4000 | 531.2000 | - | - | - | ||||||
| Provisions | 29.4000 | 25 | 115.2000 | 120.1000 | - | ||||||
| Liabilities | 689.7000 | 723.8000 | 831.9000 | 912 | - | ||||||
| Share Capital | 39.6000 | 39.6000 | - | - | - | ||||||
| Total Equity | 441.6000 | 380.4000 | 371.1000 | 498.9000 | - | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Total liabilities equity | 1,131.3000 | 1,104.2000 | 1,203 | 1,410.9000 | - | ||||||
Income Statement
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
2024 - EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 484.2000 | 515.6000 | 516.1000 | 684.6000 | - | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -1.3000 | -47.1000 | -16.6000 | 143.5000 | - | ||||||
| Interest Income | -28.2000 | -16.8000 | -13.2000 | -40 | - | ||||||
| Income Before Taxes | -30 | -62.6000 | -30.8000 | 106.3000 | - | ||||||
| Income Taxes | 1.4000 | .7000 | -.8000 | 20.7000 | - | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Net Income | -31.4000 | -63.4000 | -31.7000 | 127 | - | ||||||
Per Share
Cash Flow
|
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
2024 - EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -16.7000 | 33.9000 | -40.5000 | -2.7000 | - | ||||||
| Cash Flow from Investing Activities | -14.6000 | -23.4000 | -37 | 1.3000 | - | ||||||
| Cash Flow from Financing | 42 | 22.6000 | 89.6000 | -6.8000 | - | ||||||
| Decrease / Increase in Cash | 10.7000 | 33.1000 | - | - | - | ||||||
| Employees | 1,928 | 1,967 | 2,228 | 2,426 | - | ||||||
